| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_64b698c37801340a494f8bd80b18ba4f |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4412
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-355
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 |
| filingDate |
2006-09-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2008-06-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ecf52c6462fc90a63543fa3e4d70e592
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_10fb33a1caecf390c5cdd3c29a91dd8d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7f76ec5d709ca8a8056cfdf644701497
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ce22a6050cb104223e12d59e820ee5ed
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c2124d78e45c21e33b0e362f04bddf15
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c4e8c2400051f86b6968a7fdc6cbcbc7
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8bf123fd9993316498c980c963a2b9f6
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3e1de525b60eeb116424d79feeafdfb5 |
| publicationDate |
2008-06-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
RU-2325908-C1 |
| titleOfInvention |
Method of complication prevention accompanying combinatorial treatment of lung and venter cancer |
| abstract |
FIELD: medicine; carcinology. n SUBSTANCE: method includes anti-oxidant therapy implying preoperative intramuscular injection of tocopherol acetate of dose 300 mg and intravenous injection of mexidol of dose 200 mg. Then during operation 45-50 minutes before intraoperative radiation therapy (IORT) mexidol is reinjected dosed 400 mg, and within antienzyme therapy gordox is introduced dosed 100 000 units. Within 3-7 days after operation tocopherol acetate is injected dosed 300 mg every 8 hours and mexidol is injected dosed 200 mg every 6 hours. Method enables to make favourable conditions for IORT and reduce number of complications caused by hemorheologic damages and hypercoagulation. n EFFECT: making of favourable conditions for IORT and reduced number of complications caused by hemorheologic damages and hypercoagulation. n 6 tbl, 2 ex |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2490037-C1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2474421-C1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2489181-C1 |
| priorityDate |
2006-09-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |